Free Trial

Inspire Investing LLC Grows Position in Aehr Test Systems $AEHR

Aehr Test Systems logo with Computer and Technology background

Key Points

  • Inspire Investing LLC significantly increased its stake in Aehr Test Systems by 99.3% during the first quarter, now owning approximately 48,148 shares valued at $351,000.
  • Several other institutional investors have also expanded their holdings in Aehr Test Systems, with 69.69% of the stock now owned by institutional investors collectively.
  • Despite a recent earnings report showing a small profit, Aehr Test Systems’ stock has seen a 0.4% decline, currently trading at $26.47.
  • MarketBeat previews top five stocks to own in November.

Inspire Investing LLC boosted its stake in shares of Aehr Test Systems (NASDAQ:AEHR - Free Report) by 99.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 48,148 shares of the semiconductor company's stock after acquiring an additional 23,990 shares during the period. Inspire Investing LLC owned 0.16% of Aehr Test Systems worth $351,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Aehr Test Systems by 8.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company's stock worth $126,000 after buying an additional 1,344 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Aehr Test Systems by 5.7% in the 1st quarter. Rhumbline Advisers now owns 40,212 shares of the semiconductor company's stock worth $293,000 after buying an additional 2,165 shares in the last quarter. State of Wyoming purchased a new position in shares of Aehr Test Systems in the 4th quarter worth $67,000. Quantbot Technologies LP purchased a new position in shares of Aehr Test Systems in the 1st quarter worth $31,000. Finally, Two Sigma Investments LP grew its stake in shares of Aehr Test Systems by 12.2% in the 4th quarter. Two Sigma Investments LP now owns 48,624 shares of the semiconductor company's stock worth $809,000 after buying an additional 5,276 shares in the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.

Aehr Test Systems Stock Performance

Shares of NASDAQ:AEHR traded down $0.62 on Friday, reaching $29.95. The company's stock had a trading volume of 1,360,474 shares, compared to its average volume of 2,041,413. Aehr Test Systems has a 52-week low of $6.27 and a 52-week high of $31.65. The company has a market cap of $897.60 million, a P/E ratio of -230.37 and a beta of 2.54. The company has a 50-day simple moving average of $21.48 and a 200 day simple moving average of $13.85.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 8th. The semiconductor company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. Aehr Test Systems had a negative net margin of 6.63% and a negative return on equity of 0.15%. The business had revenue of $14.10 million during the quarter, compared to analysts' expectations of $14.83 million. On average, equities research analysts forecast that Aehr Test Systems will post 0.1 EPS for the current fiscal year.

Insider Buying and Selling

In other Aehr Test Systems news, Director Laura Oliphant sold 5,000 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $21.50, for a total value of $107,500.00. Following the completion of the sale, the director directly owned 7,665 shares of the company's stock, valued at $164,797.50. The trade was a 39.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Rhea J. Posedel sold 18,000 shares of the business's stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of $19.83, for a total transaction of $356,940.00. Following the completion of the sale, the director directly owned 71,163 shares of the company's stock, valued at approximately $1,411,162.29. This trade represents a 20.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,000 shares of company stock valued at $506,830. Company insiders own 6.80% of the company's stock.

Aehr Test Systems Profile

(Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Read More

Institutional Ownership by Quarter for Aehr Test Systems (NASDAQ:AEHR)

Should You Invest $1,000 in Aehr Test Systems Right Now?

Before you consider Aehr Test Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aehr Test Systems wasn't on the list.

While Aehr Test Systems currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.